γ-catenin inhibitors are a class of chemical compounds that target a specific protein called γ-catenin, which plays a crucial role in various cellular processes, particularly those related to cell adhesion and signaling pathways. γ-catenin is a member of the catenin family of proteins, which are primarily known for their involvement in the Wnt signaling pathway and their association with cadherins, the cell-cell adhesion molecules. Within the context of cell adhesion, γ-catenin serves as a key mediator, bridging the connection between cadherins and the actin cytoskeleton. This interaction is essential for maintaining the integrity of tissues and ensuring proper cell adhesion, which is fundamental in processes such as tissue development, homeostasis, and wound healing.
Inhibitors targeting γ-catenin are designed to interfere with its activity or expression, disrupting the normal functioning of cellular processes in which γ-catenin is involved. By modulating γ-catenin, these inhibitors influence cell adhesion, cell motility, and various signaling pathways, which can have significant implications in the context of disease research and drug development. Understanding the molecular mechanisms underlying γ-catenin inhibitors' effects is crucial for elucidating their roles in various biological contexts, including cancer, tissue regeneration, and developmental biology. Research into γ-catenin inhibitors continues to shed light on their precise mechanisms of action and their applications in manipulating cellular processes.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, a protein kinase involved in inflammatory responses. It may affect γ-catenin expression by modulating cellular signaling. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib may decrease γ-catenin expression by inducing proteasome-mediated degradation. | ||||||